Medications Updated During March 2020, From Newest to Oldest

Page 1 of 177 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

Kit For the Preparation of Technetium Tc99m Sestamibi (2)

Kit For the Preparation of Technetium Tc99m Sestamibi (TECHNETIUM TC-99M SESTAMIBI)

Myocardial Imaging: Technetium Tc 99m Sestamibi Injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia…

Sun Pharmaceutical Industries, Inc.31 March 2020

Kit For the Prepartion of Technetium Tc99m Sulfur Colloid (1)

Kit For the Prepartion of Technetium Tc99m Sulfur Colloid (Technetium Tc 99m Sulfur Colloid)

Technetium Tc 99m Sulfur Colloid Injection is indicated: In adults, to assist in the: localization of lymph nodes draining a primary tumor in patients with breast cancer or malignant…

Sun Pharmaceutical Industries, Inc.31 March 2020

Atomoxetine

Atomoxetine capsules are selective norepinephrine reuptake inhibitor indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). (1.1) 1.1…

Glenmark Pharmaceuticals Inc., USA31 March 2020

Olmesartan Medoxomil

Olmesartan medoxomil tablets are indicated for the treatment of hypertension in adults and children six years of age and older, to lower blood pressure. Lowering blood pressure reduces…

Glenmark Pharmaceuticals Inc., USA31 March 2020

Adipex-P (Phentermine Hydrochloride)

ADIPEX-P is indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification and caloric restriction in the management of…

Teva Pharmaceuticals USA, Inc.31 March 2020

Page 1 of 177 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Super Potency
Thu, 21 May 2020. Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. The products are being recalled because our testing has found these lots to be superpotent…
Biota Biosciences Issues Voluntary Nationwide Recall of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables Because They Were Marketed Without FDA Approval
Tue, 19 May 2020. Biota Biosciences is voluntarily recalling the following lots in the table below of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables to the customer level.

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.